Harbour Investments’s Akero Therapeutics AKRO Stock Holding History

Harbour Investments’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-30	Closed	-$1.42K	–	3866
2025 Q3	$1.42K	Hold	30	–	–	﹤0.01%	3348
2025 Q2	$1.6K	Hold	30	–	–	﹤0.01%	3196
2025 Q1	$1.21K	Hold	30	–	–	﹤0.01%	3197
2024 Q4	$835	Hold	30	–	–	﹤0.01%	3205
2024 Q3	$861	Hold	30	–	–	﹤0.01%	3120
2024 Q2	$704	Buy	+30	New	+$642	﹤0.01%	3047

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Harbour Investments's AKRO Position: Q4 2025 in Review

Harbour Investments sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 30 shares — an estimated $1.42K sold.

Harbour Investments first reported a position in AKRO in Q2 2024 and held it in 6 quarters. The position peaked at $1.6K in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Harbour Investments reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Harbour Investments sold 30 Akero Therapeutics shares in Q4 2025, an estimated $1.42K.
Harbour Investments first reported a position in Akero Therapeutics in Q2 2024 and held it in 6 quarters.
Harbour Investments's Akero Therapeutics position peaked at $1.6K in Q2 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Harbour Investments's 13F filing for Q4 2025, filed 9 Feb 2026.